Multicenter Analysis of 80 Solid Organ Transplantation Recipients With Post-Transplantation Lymphoproliferative Disease: Outcomes and Prognostic Factors in the Modern Era Event-free survival following ...
VIENNA — The groundbreaking chemotherapy-free combination of arsenic trioxide and all-trans retinoic acid (ATO/ATRA) is effective in the treatment of high-risk acute promyelocytic leukemia (APL) ...
In a phase 3 trial of 133 patients with high-risk acute promyelocytic leukemia (APL), all-trans retinoic acid and arsenic trioxide (ATRA-ATO) therapy demonstrated superior 2-year event-free survival ...
Changes in Frequency of Surveillance Imaging of Survivors of Diffuse Large B-Cell Lymphoma After the American Society of Hematology Choosing Wisely Recommendations Acute promyelocytic leukemia (APL) ...
Information on 103 patients with t-APL occurring after chemotherapy and/or radiation for a previous neoplasm or non-malignant disorder between 1991 and 2015 was collected from 11 study ...
All-trans retinoic acid (ATRA) with chemotherapy is the standard of care for acute promyelocytic leukemia (APL), resulting in cure rates exceeding 80%. Pilot studies of treatment with arsenic trioxide ...
Acute promyelocytic leukaemia (APL) is a distinct subtype of acute myeloid leukaemia driven by the PML-RARA fusion oncoprotein, which blocks differentiation of myeloid precursors at the promyelocyte ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results